(MO) Altria - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US02209S1033

Cigarettes, Cigars, Smokeless, Nicotine Pouches, E-Vapor

Tobacco
Market Cap in USD: 93,906m

IPO / Inception: 1970-01-02
12m vs SPY: 1.98%

EPS (Earnings per Share)

EPS CAGR: 7.91%
EPS Trend: 69.5%

Last SUE: 0.00
Qual. Beats: 0

Revenue

Rev. CAGR: 0.86%
Rev. Trend: -4.5%

Last SUE: -0.04
Qual. Beats: 0

Dividends

Dividend Yield	7.00%
Yield on Cost 5y	14.94%
Yield CAGR 5y	4.26%
Payout Consistency	98.4%
Payout Ratio	76.9%

Risk via 5d forecast
Volatility	19.2%
Value at Risk 5%th	29.3%
Relative Tail Risk	-7.13%

Reward TTM
Sharpe Ratio	0.94
Alpha	18.08
CAGR/Max DD	1.11

Character TTM
Hurst Exponent	0.485
Beta	-0.022
Beta Downside	0.150

Drawdowns 3y
Max DD	16.40%
Mean DD	4.68%
Median DD	3.90%

Description: MO Altria December 02, 2025

Altria Group, Inc. (NYSE: MO) manufactures and markets a portfolio of combustible and oral tobacco products in the United States, including Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal smokeless tobacco, the on! nicotine-pouch line, and NJOY ACE e-vapor devices, primarily sold through distributors and large retail chains.

Key recent metrics: 2023 net revenue was approximately $15.5 billion with an adjusted earnings-before-interest-tax-depreciation-amortization (EBITDA) margin near 30 %, reflecting strong pricing power despite a declining smoker base. The company’s dividend yield remains high at roughly 8 %, a core attraction for income-focused investors. Altria’s growth outlook hinges on the performance of reduced-risk products (RRPs) such as nicotine pouches, which currently account for about 5 % of total sales and are projected to reach double-digit contribution by 2026, while regulatory risk and shifting consumer preferences continue to shape the tobacco sector.

For a deeper, data-driven assessment of Altria’s valuation and risk profile, you might explore the analytical tools available on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (8.87b TTM) > 0 and > 6% of Revenue (6% = 1.21b TTM)

FCFTA 0.26 (>2.0%) and ΔFCFTA 1.39pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -15.70% (prev -22.09%; Δ 6.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.27 (>3.0%) and CFO 9.36b > Net Income 8.87b (YES >=105%, WARN >=100%)

Net Debt (22.23b) to EBITDA (12.10b) ratio: 1.84 <= 3.0 (WARN <= 3.5)

Current Ratio 0.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.68b) change vs 12m ago -1.12% (target <= -2.0% for YES)

Gross Margin 71.98% (prev 70.04%; Δ 1.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 58.30% (prev 59.60%; Δ -1.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 11.04 (EBITDA TTM 12.10b / Interest Expense TTM 1.07b) >= 6 (WARN >= 3)

Altman Z'' 6.02

(A) -0.09 = (Total Current Assets 5.12b - Total Current Liabilities 8.29b) / Total Assets 35.01b

(B) 1.03 = Retained Earnings (Balance) 36.12b / Total Assets 35.01b

warn (B) unusual magnitude: 1.03 — check mapping/units

(D) 0.91 = Book Value of Equity 34.34b / Total Liabilities 37.60b

Total Rating: 6.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 73.91

1. Piotroski 6.50pt

2. FCF Yield 7.91%

3. FCF Margin 45.56%

4. Debt/Equity -9.71

5. Debt/Ebitda 1.84

6. ROIC - WACC (= 35.89)%

7. RoE -304.5%

8. Rev. Trend -4.51%

9. EPS Trend 69.50%

What is the price of MO shares?

As of January 14, 2026, the stock is trading at USD 58.54 with a total of 6,670,100 shares traded.
Over the past week, the price has changed by +3.98%, over one month by +1.47%, over three months by -8.22% and over the past year by +23.37%.

Is MO a buy, sell or hold?

Altria has received a consensus analysts rating of 3.27. Therefor, it is recommend to hold MO.

Strong Buy: 3
Buy: 1
Hold: 9
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the MO price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	62.4	6.6%
Analysts Target Price	62.4	6.6%
ValueRay Target Price	72	23%

MO Fundamental Data Overview January 10, 2026

P/E Trailing = 10.6679
P/E Forward = 9.7752
P/S = 4.6566
P/B = 27.3016
P/EG = 4.0147
Beta = 0.501
Revenue TTM = 20.17b USD
EBIT TTM = 11.81b USD
EBITDA TTM = 12.10b USD
Long Term Debt = 24.13b USD (from longTermDebt, last quarter)
Short Term Debt = 1.57b USD (from shortTermDebt, last quarter)
Debt = 25.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.23b USD (from netDebt column, last quarter)
Enterprise Value = 116.13b USD (93.91b + Debt 25.70b - CCE 3.47b)
Interest Coverage Ratio = 11.04 (Ebit TTM 11.81b / Interest Expense TTM 1.07b)
EV/FCF = 12.64x (Enterprise Value 116.13b / FCF TTM 9.19b)
FCF Yield = 7.91% (FCF TTM 9.19b / Enterprise Value 116.13b)
FCF Margin = 45.56% (FCF TTM 9.19b / Revenue TTM 20.17b)
Net Margin = 43.98% (Net Income TTM 8.87b / Revenue TTM 20.17b)
Gross Margin = 71.98% ((Revenue TTM 20.17b - Cost of Revenue TTM 5.65b) / Revenue TTM)
Gross Margin QoQ = 72.60% (prev 72.78%)
Tobins Q-Ratio = 3.32 (Enterprise Value 116.13b / Total Assets 35.01b)
Interest Expense / Debt = 1.08% (Interest Expense 278.0m / Debt 25.70b)
Taxrate = 22.76% (700.0m / 3.08b)
NOPAT = 9.12b (EBIT 11.81b * (1 - 22.76%))
Current Ratio = 0.62 (Total Current Assets 5.12b / Total Current Liabilities 8.29b)
Debt / Equity = -9.71 (negative equity) (Debt 25.70b / totalStockholderEquity, last quarter -2.65b)
Debt / EBITDA = 1.84 (Net Debt 22.23b / EBITDA 12.10b)
Debt / FCF = 2.42 (Net Debt 22.23b / FCF TTM 9.19b)
Total Stockholder Equity = -2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 25.64% (Net Income 8.87b / Total Assets 35.01b)
RoE = -304.5% (negative equity) (Net Income TTM 8.87b / Total Stockholder Equity -2.91b)
RoCE = 55.66% (EBIT 11.81b / Capital Employed (Equity -2.91b + L.T.Debt 24.13b))
RoIC = 40.65% (NOPAT 9.12b / Invested Capital 22.44b)
WACC = 4.76% (E(93.91b)/V(119.61b) * Re(5.83%) + D(25.70b)/V(119.61b) * Rd(1.08%) * (1-Tc(0.23)))
Discount Rate = 5.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.41%
[DCF Debug] Terminal Value 86.51% ; FCFF base≈8.91b ; Y1≈9.07b ; Y5≈9.94b
Fair Price DCF = 163.0 (EV 295.80b - Net Debt 22.23b = Equity 273.57b / Shares 1.68b; r=5.90% [WACC]; 5y FCF grow 1.52% → 2.90% )
EPS Correlation: 69.50 | EPS CAGR: 7.91% | SUE: 0.0 | # QB: 0
Revenue Correlation: -4.51 | Revenue CAGR: 0.86% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.26 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=5.59 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+2.8% | Growth Revenue=-0.1%

Additional Sources for MO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle